Karen Marie Johnson is Director of Oncology Institute, Inc.. Currently has a direct ownership of 167,185 shares of TOI, which is worth approximately $35,108. The most recent transaction as insider was on Nov 22, 2024, when has been sold 52,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 167K
45.14% 3M change
164.6% 12M change
Total Value Held $35,108

Karen Marie Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2024
BUY
Grant, award, or other acquisition
-
52,000 Added 23.72%
167,185 Common Stock
Dec 26 2023
BUY
Grant, award, or other acquisition
-
52,000 Added 31.1%
115,185 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
19,685 Added 23.75%
63,185 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
22,708 Added 34.3%
43,500 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
20,792 Added 50.0%
20,792 Common Stock
KMJ

Karen Marie Johnson

Director
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI